InforSense Initiates Annual 'Open House'
News Dec 05, 2005
InforSense Ltd has hosted customers, partners and investors at the company’s London headquarters last week to hear how their integrative analytics platform, InforSense KDE, is providing information-driven insights across a wide variety of industries.
Presenters, including Stephen Calvert, Vice President of Cheminformatics at GlaxoSmithKline and Michael Liebman, Executive Director of the Windber Research Institute, highlighted some of the drug discovery, health care and financial contexts in which InforSense KDE is used as an enterprise environment for business-critical decision-making.
"Many industries face the same challenge of enabling decision-makers to access and use information in a way that keeps pace with changing business needs," said Prof. Yike Guo, CEO and Founder of InforSense.
"InforSense service-oriented workflow technology effectively addresses this challenge by enabling the creation of a single platform to support entire information-driven decision-making processes."
"We see InforSense KDE increasingly adopted by companies in a wide range of sectors as a uniform environment for enterprise-wide decision support."
Bicycle Therapeutics Expands Strategic Partnership with AstraZenecaNews
New programs added in respiratory and cardio-metabolic diseases.READ MORE
Worldwide Clinical Trials Receives 2018 CRO Leadership AwardsNews
Life Science Leader and Industry Standard Research assess 70 contract research organizations, honoring Worldwide Clinical Trials for fifth consecutive year.READ MORE
WuXi Biologics to Invest in Biologics Manufacturing Facility in SingaporeNews
WuXi Biologics' first overseas site in Asia.READ MORE
Comments | 0 ADD COMMENT
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018